Oncology
Revealing the molecular mechanism of tumor development and identifying the matching inhibitory candidates is one important area within the cancer research.
The tumor diversity is extremely high. Therefore, cancer research belongs to the high variant research areas with manifold scientific approaches.
To match this challenge, we offer you a unique diversity of products for your oncology research and development in the academic and pharmaceutical field.
Click on the organs and learn more about cancer types
General information
Oncologists focus on the diagnosis, therapy and follow-up of cancer.
Cancer is a class of diseases in which cells start to divide uncontrollably and invade other tissues. Cancer cells can spread to other parts of the body via the blood and lymphatic system. Under physiological conditions, cell proliferation is tightly controlled by many mechanisms. In addition, the immune system is able to recognize and destroy cancer cells. If these mechanisms fail or the immune system cannot effectively destroy the cells, it can lead to a malignant tumor. Theoretically, a malignant neoplasm can occur everywhere, but there are cancers that are more often than others. For men it is the prostate and in women it is the mammary gland.
Relevant products for oncology research
Name | Price | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Anti-ABHD1 antibody (220-300 aa) (STJ190491) | Login | Anti-ABHD1 antibody (220-300 aa) (STJ190491) | ||||||||||||||||
|
||||||||||||||||||
Anti-CTNNAL1 antibody (150-230 aa) (STJ190539) | Login | Anti-CTNNAL1 antibody (150-230 aa) (STJ190539) | ||||||||||||||||
|
||||||||||||||||||
Anti-TGIF2LX antibody (STJ190177) | Login | Anti-TGIF2LX antibody (STJ190177) | ||||||||||||||||
|
||||||||||||||||||
Anti-ANXA11 antibody (280-360 aa) (STJ190554) | Login | Anti-ANXA11 antibody (280-360 aa) (STJ190554) | ||||||||||||||||
|
||||||||||||||||||
Anti-PITX3 antibody (10-90 aa) (STJ190186) | Login | Anti-PITX3 antibody (10-90 aa) (STJ190186) | ||||||||||||||||
|
||||||||||||||||||
Anti-CDKL5 antibody (30-110 aa) (STJ190188) | Login | Anti-CDKL5 antibody (30-110 aa) (STJ190188) | ||||||||||||||||
|
||||||||||||||||||
Anti-DUSP14 antibody (120-200 aa) (STJ190190) | Login | Anti-DUSP14 antibody (120-200 aa) (STJ190190) | ||||||||||||||||
|
||||||||||||||||||
Anti-PPP2R1A antibody (500-580 aa) (STJ190194) | Login | Anti-PPP2R1A antibody (500-580 aa) (STJ190194) | ||||||||||||||||
|
||||||||||||||||||
Anti-MAPK4 antibody (410-490 aa) (STJ190195) | Login | Anti-MAPK4 antibody (410-490 aa) (STJ190195) | ||||||||||||||||
|
||||||||||||||||||
Anti-ID1 antibody (30-110 aa) (STJ190197) | Login | Anti-ID1 antibody (30-110 aa) (STJ190197) | ||||||||||||||||
|
||||||||||||||||||
Anti-TNIP3 antibody (40-120 aa) (STJ190437) | Login | Anti-TNIP3 antibody (40-120 aa) (STJ190437) | ||||||||||||||||
|
||||||||||||||||||
Anti-EFNB2 antibody (210-290 aa) (STJ190200) | Login | Anti-EFNB2 antibody (210-290 aa) (STJ190200) | ||||||||||||||||
|
||||||||||||||||||
Anti-SUPT4H1 antibody (40-120 aa) (STJ190203) | Login | Anti-SUPT4H1 antibody (40-120 aa) (STJ190203) | ||||||||||||||||
|
||||||||||||||||||
Anti-MRPS11 antibody (10-90 aa) (STJ190204) | Login | Anti-MRPS11 antibody (10-90 aa) (STJ190204) | ||||||||||||||||
|
||||||||||||||||||
Anti-U2AF1 antibody (60-140 aa) (STJ190205) | Login | Anti-U2AF1 antibody (60-140 aa) (STJ190205) | ||||||||||||||||
|
||||||||||||||||||
Anti-FOXM1 antibody (190-270 aa) (STJ190208) | Login | Anti-FOXM1 antibody (190-270 aa) (STJ190208) | ||||||||||||||||
|
||||||||||||||||||
Anti-EPS8 antibody (130-210 aa) (STJ190210) | Login | Anti-EPS8 antibody (130-210 aa) (STJ190210) | ||||||||||||||||
|
||||||||||||||||||
Anti-TAF10 antibody (130-210 aa) (STJ190211) | Login | Anti-TAF10 antibody (130-210 aa) (STJ190211) | ||||||||||||||||
|
||||||||||||||||||
Anti-COASY antibody (260-340 aa) (STJ190213) | Login | Anti-COASY antibody (260-340 aa) (STJ190213) | ||||||||||||||||
|
||||||||||||||||||
Anti-HSD3B1 antibody (30-110 aa) (STJ190453) | Login | Anti-HSD3B1 antibody (30-110 aa) (STJ190453) | ||||||||||||||||
|
||||||||||||||||||
Anti-MTF1 antibody (260-340 aa) (STJ190218) | Login | Anti-MTF1 antibody (260-340 aa) (STJ190218) | ||||||||||||||||
|
||||||||||||||||||
Anti-SART3 antibody (40-120 aa) (STJ190220) | Login | Anti-SART3 antibody (40-120 aa) (STJ190220) | ||||||||||||||||
|
||||||||||||||||||
Anti-PDGFRL antibody (50-130 aa) (STJ190221) | Login | Anti-PDGFRL antibody (50-130 aa) (STJ190221) | ||||||||||||||||
|
||||||||||||||||||
Anti-PCBP1 antibody (30-110 aa) (STJ190222) | Login | Anti-PCBP1 antibody (30-110 aa) (STJ190222) | ||||||||||||||||
|
||||||||||||||||||
Anti-PCBP2 antibody (30-110 aa) (STJ190223) | Login | Anti-PCBP2 antibody (30-110 aa) (STJ190223) | ||||||||||||||||
|